CMS WISeR 2026 Impact on IR Practices

Why This Matters Right Now

Performing CPT 37222 in an Office-Based Lab (OBL) now yields $4,076 in commercial revenue, a figure that starkly contrasts with the gradually decreasing reimbursements from CMS. The introduction of the CMS WISeR 2026 prior authorization regulations represents a paradigm shift for interventional radiologists, emphasizing the need to adapt swiftly to maintain financial viability. The urgency is underscored by the significant market signal indicating new prior authorization hurdles, highlighting the necessity for strategic adjustments in clinical workflows.

As an interventional radiologist with over two decades of experience, I witness firsthand the financial and logistical challenges that prior authorization presents. Recently, a patient with a recurrent peripheral artery disease required a revascularization procedure coded under 37224. Despite the clinical necessity, prior authorization lagged, delaying treatment. Collaborating with Nakod Prior Auth Intelligence has become indispensable in navigating these complexities efficiently.

The Numbers — Financial Impact of Key Procedures

The financial impact of specific medical procedures is a critical component of decision-making in interventional radiology practices. Understanding the revenue differences between outpatient-based labs (OBLs) and hospitals can guide strategic planning and resource allocation. For instance, the CPT code 36901, which pertains to a dialysis circuit, generates a revenue of $1,200 in an OBL setting compared to $950 in a hospital. This discrepancy highlights the potential profitability of performing certain procedures outside the traditional hospital environment.

Similarly, CPT code 36902, involving more complex interventions within dialysis circuits, yields $1,450 in OBL revenue versus $1,100 in hospital revenue, underscoring a consistent trend where OBLs offer higher income potential. This trend is further exemplified with CPT code 37222, which involves stent procedures for arteries, generating $4,076 in an OBL compared to $3,500 in a hospital setting. Such data suggests that OBLs can offer a more lucrative financial model for certain types of procedures.

These figures illustrate a broader market trend where OBLs are increasingly becoming attractive venues for both patients and providers due to their ability to deliver cost-effective care with potentially higher reimbursement rates. Therefore, IR practices should consider the strategic implications of these financial differentials when planning their service offerings and expansions.

Clinical Context

The patient population most impacted by these CMS WISeR 2026 changes predominantly includes individuals with chronic vascular conditions, such as peripheral artery disease and deep vein thrombosis. These patients often require ongoing interventional management. The referral dynamics within this landscape are evolving, leading to a substantial increase in the administrative burden on radiologists. These pre-authorization requirements can lead to procedural delays.

Radiologists must now navigate these new requirements effectively, utilizing comprehensive documentation to justify the clinical necessity of procedures. This is critical as payer scrutiny intensifies. As a response, IR practices are increasingly integrating financial acumen with clinical decision-making. Advanced patient management software is designed to reduce authorization-related delays. Furthermore, these changes emphasize the importance of maintaining clear communication with referring physicians. In this evolving environment, a strategic approach combining clinical expertise with an understanding of payer expectations is crucial for minimizing disruptions in patient care.

OBL vs Hospital: What the Math Actually Looks Like

Analyzing revenue streams, OBLs often demonstrate higher profitability for numerous procedures, particularly within the realm of interventional radiology. For example, CPT 37220, a common peripheral intervention code, may be reimbursed at different rates in OBLs compared to hospital settings.

However, the financial landscape is not without challenges. The CMS WISeR 2026 initiative introduces stringent prior authorization requirements, which can complicate the reimbursement process for outpatient procedures. This complexity can add to the administrative workload for a practice.

In this competitive landscape, efficiency in managing prior authorizations becomes paramount. Practices can mitigate these challenges by leveraging advanced technology solutions. Utilizing CMS.gov. Physicians focused on optimizing their response to these regulatory changes can leverage

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — June 27, 2026